Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 42 entries
View as:

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03386851 Org: User:
Start: 12/13/16 End: 05/25/21 Due: 05/25/22

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT04189705 Org: User:
Start: 12/30/19 End: 04/23/20 Due: 04/23/21

Samsca Post Marketing Surveillance Study

Phase: N/A Priority: Normal
NCT ID: NCT02722863 Org: User:
Start: 07/09/13 End: 06/15/17 Due: 06/15/18

Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)

Phase: N/A Priority: Normal
NCT ID: NCT00304655 Org: User:
Start: 07/31/04 End: 10/31/07 Due: 10/31/08

Pletaal SR Post Marketing Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT01782833 Org: User:
Start: 01/31/13 End: 12/31/14 Due: 12/31/15

Pharmacokinetics Study for Probucol

Phase: N/A Priority: Normal
NCT ID: NCT01000467 Org: User:
Start: 02/28/09 End: 09/30/09 Due: 09/30/10

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Phase: N/A Priority: Normal
NCT ID: NCT00272454 Org: User:
Start: 01/31/06 End: 09/30/08 Due: 09/30/09

Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT02250170 Org: User:
Start: 10/23/14 End: 03/08/19 Due: 03/08/20

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Phase: N/A Priority: Normal
NCT ID: NCT03376763 Org: User:
Start: 11/21/17 End: 11/19/21 Due: 11/19/22

Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety

Phase: N/A Priority: Normal
NCT ID: NCT01142284 Org: User:
Start: 05/19/10 End: 12/18/12 Due: 12/18/13

Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01726816 Org: User:
Start: 10/31/12 End: 09/30/14 Due: 09/30/15

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00216723 Org: User:
Start: 04/30/04 End: 12/31/09 Due: 12/31/10

Safety and Pharmacokinetics of Probucol and Cilostazol

Phase: N/A Priority: Normal
NCT ID: NCT00549978 Org: User:
Start: 10/31/07 End: 08/31/08 Due: 08/31/09

Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites

Phase: N/A Priority: Normal
NCT ID: NCT01552590 Org: User:
Start: 04/30/12 End: 04/30/12 Due: 04/30/13

Efficacy and Safety of Cilostazol for the Indication of CSPS

Phase: N/A Priority: Normal
NCT ID: NCT00216749 Org: User:
Start: 12/31/03 End: 10/31/07 Due: 10/31/08

A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT01711333 Org: User:
Start: 10/26/12 End: 08/18/14 Due: 08/18/15

Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT03949894 Org: User:
Start: 07/01/19 End: 05/25/22 Due: 05/25/23

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

Phase: N/A Priority: Normal
NCT ID: NCT02094469 Org: User:
Start: 12/31/13 End: 01/31/16 Due: 01/31/17

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01925521 Org: User:
Start: 08/31/13 End: 04/30/14 Due: 04/30/15

Samsca PMS in ADPKD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03406286 Org: User:
Start: 07/19/16 End: 11/30/25 Due: 11/30/26

An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00657176 Org: User:
Start: 03/31/08 End: 06/30/09 Due: 06/30/10

A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00993317 Org: User:
Start: 10/31/09 End: 08/31/11 Due: 08/31/12

Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male

Phase: N/A Priority: Normal
NCT ID: NCT01014416 Org: User:
Start: 01/31/10 End: 03/31/10 Due: 03/31/11

PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT00576706 Org: User:
Start: 12/31/07 End: 03/31/10 Due: 03/31/11

Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness

Phase: N/A Priority: Normal
NCT ID: NCT00545142 Org: User:
Start: 10/31/07 End: 06/30/10 Due: 06/30/11